The US food and drug administration issued a warning for Johnson and Johnson’s covid 19 vaccine , saying data suggests an increased risk
of a rare autoimmune disorder called Keonbare.  Also known as gbs the syndrome is a rare neurological condition,

in which the body’s immune system attacks the protective coating, on nerve fibers most people fully recover in a monday letter to the company the fda said the chances of getting gbs was quote very low, but still warned that recipients of the j j vaccine should seek medical attention.

If they show symptoms within six weeks of inoculation including weakness tingling sensations difficulty walking or difficulty with facial movements. Most cases were in men over the age of 50. Nearly 13 million people have received J and J’s one dose vaccine in the USA.

Out of 100 preliminary reports of gbs the fda says 95 cases have required hospitalization. The warning is another setback for the J J shot as its one dose system was supposed to help vaccinate hard-to-reach areas.

Last week European regulators issued a similar warning for astrazeneca’s vaccine which uses technology like j j’s a traditional virus-based. Approach meanwhile the fda has not linked gbs to the mrna vaccines pfizer bioattack and moderna English (auto-generated).